QIM
NKTR icon

Quantitative Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Quantitative Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,655
Closed -$796K – 533
2021
Q1 		$796K Buy
+2,655
New +$826K 0.07% 262
2020
Q3 		– Sell
-4,556
Closed -$1.58M – 545
2020
Q2 		$1.58M Buy
4,556
+3,788
+493% +$1.18M 0.16% 142
2020
Q1 		$205K Buy
+768
New +$238K 0.02% 447
2019
Q2 		– Sell
-1,920
Closed -$967K – 767
2019
Q1 		$967K Sell
1,920
-240
-11% -$142K 0.06% 378
2018
Q4 		$1.06M Buy
2,160
+900
+71% +$543K 0.05% 272
2018
Q3 		$1.15M Sell
1,260
-12,820
-91% -$10.9M 0.04% 279
2018
Q2 		$10.3M Buy
+14,080
New +$16.2M 0.21% 101
2016
Q4 		– Sell
-4,607
Closed -$1.19M – 903
2016
Q3 		$1.19M Buy
4,607
+714
+18% +$184K 0.04% 419
2016
Q2 		$831K Buy
+3,893
New +$870K 0.04% 465
2016
Q1 		– Sell
-1,120
Closed -$283K – 876
2015
Q4 		$283K Sell
1,120
-1,733
-61% -$356K 0.02% 599
2015
Q3 		$469K Buy
2,853
+186
+7% +$32.9K 0.04% 454
2015
Q2 		$500K Buy
+2,667
New +$459K 0.08% 233
2014
Q3 		– Sell
-793
Closed -$152K – 454
2014
Q2 		$152K Buy
+793
New +$140K 0.03% 416
2013
Q4 		– Sell
-667
Closed -$104K – 677
2013
Q3 		$104K Buy
+667
New +$123K 0.01% 519

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Quantitative Investment Management's NKTR Position: Q2 2021 in Review

Quantitative Investment Management sold out of Nektar Therapeutics (NKTR) in Q2 2021, closing a stake of 2,655 shares — an estimated $796K sold.

Quantitative Investment Management first reported a position in NKTR in Q3 2013 and held it in 14 quarters. The position peaked at $10.3M in Q2 2018. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2021.

  • Quantitative Investment Management reported no remaining Nektar Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 2,655 Nektar Therapeutics shares in Q2 2021, an estimated $796K.
  • Quantitative Investment Management first reported a position in Nektar Therapeutics in Q3 2013 and held it in 14 quarters.
  • Quantitative Investment Management's Nektar Therapeutics position peaked at $10.3M in Q2 2018.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2021.

Based on Quantitative Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.